Skip to content

Study · Not a test of the peptide alone · 2020

1 result

Geometrical optimisation of a personalised microneedle eye patch for transdermal delivery of anti-wrinkle small peptide.

Lim SH, Tiew WJ, Zhang J, Ho PC, Kachouie NN, Kang L

Biofabrication9 Apr 2020Cited by 49 (Europe PMC)

PMID31952064 (opens in a new tab)DOI10.1088/1758-5090/ab6d37 (opens in a new tab)PepBankPUB-31952064
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Argireline (acetyl hexapeptide-8) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Argireline (acetyl hexapeptide-8).

  1. 01LabNot a test of Argireline (acetyl hexapeptide-8) aloneEx vivo tissuePharmacokinetics

    In vitro, the personalized microneedle patch enhanced transdermal delivery of acetyl-hexapeptide-3.

    In plain wordsIn lab tests, the personalized microneedle patch increased delivery of acetyl-hexapeptide-3 through skin.

    Peptide
    Argireline (acetyl hexapeptide-8)
    Outcome
    IncreaseTransdermal delivery
    Study

    n: not reported in source

    Skin permeation model
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In vitro skin permeation study demonstrated enhanced transdermal delivery of AHP-3 using the fabricated PMNP.

    In this study, Argireline (acetyl hexapeptide-8) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Argireline (acetyl hexapeptide-8).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.